R Luukkainen Selected Research

R Luukkainen Research Topics

8	Rheumatoid Arthritis 05/2011 - 11/2000
2	Necrosis 11/2006 - 02/2001
2	Rheumatic Diseases (Rheumatism) 08/2006 - 09/2003
2	Reactive Arthritis (Reiter Disease) 09/2003 - 07/2000
1	Low Back Pain (Lumbago) 03/2005
1	Spondylarthropathies 09/2003
1	Ankylosing Spondylitis 09/2003
1	Anterior Uveitis 09/2003
1	Arthritis (Polyarthritis) 03/2002
1	Rheumatoid Nodule 04/2001
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2001
1	Infections 07/2000

5	Antirheumatic Agents (DMARD)IBA 05/2011 - 11/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2006 - 03/2002
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 03/2005 - 09/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2003 - 07/2000
2	Ciprofloxacin (Cipro)FDA LinkGeneric 09/2003 - 07/2000
1	acetyl 4-aminosalicylic acidIBA 05/2011
1	AntibodiesIBA 05/2011
1	Anti-Citrullinated Protein AntibodiesIBA 05/2011
1	cyclic citrullinated peptideIBA 05/2011
1	ametantrone (HAQ)IBA 03/2009
1	factor AIBA 11/2006
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2006
1	Methotrexate (Mexate)FDA LinkGeneric 11/2006
1	Prednisolone (Predate)FDA LinkGeneric 11/2006
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 11/2006
1	Biological ProductsIBA 08/2006
1	HLA-DR Antigens (HLA-DR)IBA 11/2004
1	EpitopesIBA 11/2004
1	Rheumatoid FactorIBA 04/2001
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2001
1	Collagen Type I (Type I Collagen)IBA 04/2001
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2001
1	Interleukin-10 (Interleukin 10)IBA 02/2001
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2001

4	Therapeutics 03/2009 - 11/2000
1	Remission Induction 11/2006